Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CELZ · Entity 8127 | Director | July 20, 2021 | July 22, 2021 |
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.TSOI · Entity 87112 | Director | October 01, 2024 | October 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Report date July 20, 2021 · Filed July 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,529,522 |
Ending reported balance
After 2021-07-22 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-07-20 · Sale · Disposed 1,400,000 · Balance 7,479,522 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges. Row 2 · 2021-07-21 · Sale · Disposed 1,500,000 · Balance 5,979,522 F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price. Row 3 · 2021-07-22 · Sale · Disposed 1,450,000 · Balance 4,529,522 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price. |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 17,245 |
Reported balance
Holding disclosure · report date 2021-07-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 17,245 F4: Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
F4: Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Report date October 01, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 207,000,000 |
Reported balance
After 2024-09-30 transaction · row 1
1 source rowRow 1 · 2024-09-30 · Grant · Acquired 10,000,000 · Balance 207,000,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2024 Filed Oct 2, 2024 13:18 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $9,000.00 |
DisclosureSEC source: 0001493152-24-039151 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,000,000 Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 15:42 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $6,000.00 |
DisclosureSEC source: 0001493152-24-027081 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,000,000 Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 16:44 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $8,000.00 |
DisclosureSEC source: 0001493152-24-026656 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,000,000 Read SEC document |
| May 30, 2024 Filed May 31, 2024 08:46 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $8,000.00 |
DisclosureSEC source: 0001493152-24-022093 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,000,000 Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 15:59 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 15,000,000 | $0.00 | $10,500.00 |
DisclosureSEC source: 0001493152-24-015326 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,000,000 Read SEC document |
| February 26, 2024 Filed Feb 26, 2024 14:15 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $9,000.00 |
DisclosureSEC source: 0001493152-24-007810 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,000,000 Read SEC document |
| October 16, 2023 Filed Oct 16, 2023 19:17 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 20,000,000 | $0.00 | $30,000.00 |
DisclosureSEC source: 0001493152-23-037416 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,000,000 Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:38 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 4,000,000 | $0.00 | $19,600.00 |
DisclosureSEC source: 0001493152-23-000989 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,000,000 Read SEC document |
| December 30, 2022 Filed Dec 30, 2022 17:26 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 4,000,000 | $0.01 | $24,000.00 |
DisclosureSEC source: 0001493152-22-037188 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,000,000 Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 17:13 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 3,000,000 | $0.01 | $29,700.00 |
DisclosureSEC source: 0001493152-22-030365 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,000,000 Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 17:21 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 2,000,000 | $0.01 | $23,200.00 |
DisclosureSEC source: 0001493152-22-025529 · ownership.xml · nonDerivative · entry 5 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,000,000 Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 14:30 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 2,000,000 | $0.03 | $50,200.00 |
DisclosureSEC source: 0001493152-22-009251 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,000,000 Read SEC document |
| February 16, 2022 Filed Sep 9, 2022 17:21 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GiftCommon Stock | 20,000,000 | $0.02 | $472,000.00 |
DisclosureSEC source: 0001493152-22-025529 · ownership.xml · nonDerivative · entry 4 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,000,000 Read SEC document |
| February 16, 2022 Filed Sep 9, 2022 17:21 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GiftCommon Stock | 20,000,000 | $0.02 | $472,000.00 |
DisclosureSEC source: 0001493152-22-025529 · ownership.xml · nonDerivative · entry 3 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,000,000 Read SEC document |
| February 14, 2022 Filed Sep 9, 2022 17:21 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GiftCommon Stock | 10,000,000 | $0.02 | $226,000.00 |
DisclosureSEC source: 0001493152-22-025529 · ownership.xml · nonDerivative · entry 2 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000,000 Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 15:52 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 2,500,000 | $0.03 | $80,000.00 |
DisclosureSEC source: 0001493152-21-030089 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,000,000 Read SEC document |
| July 22, 2021 Filed Jul 22, 2021 20:54 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 1,450,000 | $0.03 | $43,645.00 |
DisclosureSEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 3 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,529,522 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 20:54 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 1,500,000 | $0.03 | $46,200.00 |
DisclosureSEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 2 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,979,522 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:54 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 1,400,000 | $0.03 | $42,560.00 |
DisclosureSEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,479,522 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 16:30 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | GrantWarrant to Purchase Common Stock · Derivative | 5,000,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001477932-21-004707 · form4.xml · derivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2031-07-15 Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 09:19 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | Exercise / conversionWarrant to Purchase Common Stock · Derivative | 10,000,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001477932-21-004334 · form4.xml · derivative · entry 4 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000,000 shares Expires 2030-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 09:19 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | Tax withholdingCommon Stock | 1,120,448 | $0.04 | $39,999.99 |
DisclosureSEC source: 0001477932-21-004334 · form4.xml · nonDerivative · entry 2 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,879,552 F1 · security: Reflects 1,120,448 shares of common stock withheld by issuer at a market price of $0.0357 per share to fund the cashless exercise of 10,000,000 shares of common stock acquired upon exercise of the Warrant identified in Table II. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 09:19 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | Exercise / conversionCommon Stock | 10,000,000 | $0.00 | $40,000.00 |
DisclosureSEC source: 0001477932-21-004334 · form4.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 13:39 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 1,000,000 | $0.05 | $46,400.00 |
DisclosureSEC source: 0001078782-21-000570 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,000,000 Read SEC document |
| March 10, 2021 Filed Mar 10, 2021 10:36 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GiftCommon Stock | 5,000,000 | $0.07 | $365,000.00 |
DisclosureSEC source: 0001078782-21-000215 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,000,000 Read SEC document |
| March 05, 2021 Filed Sep 9, 2022 17:21 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GiftCommon Stock | 5,000,000 | $0.08 | $375,000.00 |
DisclosureSEC source: 0001493152-22-025529 · ownership.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,000,000 Read SEC document |
| December 30, 2020 Filed Dec 30, 2020 16:12 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 3,000,000 | $0.01 | $18,000.00 |
DisclosureSEC source: 0001078782-20-001026 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,000,000 Read SEC document |
| December 28, 2020 Filed Dec 31, 2020 16:30 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | GrantWarrant to Purchase Common Stock · Derivative | 10,000,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001477932-20-007593 · form4.xml · derivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000,000 Underlying: Common Stock · 10,000,000 shares Expires 2030-12-28 Read SEC document |
| December 17, 2020 Filed Dec 17, 2020 16:38 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 5,000,000 | $0.01 | $33,500.00 |
DisclosureSEC source: 0001078782-20-000978 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,000,000 Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 16:34 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 5,000,000 | $0.01 | $43,000.00 |
DisclosureSEC source: 0001078782-20-000741 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,000,000 Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 14:40 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 5,000,000 | $0.01 | $35,500.00 |
DisclosureSEC source: 0001078782-20-000727 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000,000 Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 12:42 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 3,000,000 | $0.01 | $23,100.00 |
DisclosureSEC source: 0001078782-20-000574 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,000,000 Read SEC document |
| July 17, 2020 Filed Jul 17, 2020 17:00 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 2,500,000 | $0.01 | $15,750.00 |
DisclosureSEC source: 0001078782-20-000552 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,000,000 Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 14:41 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 5,000,000 | $0.01 | $41,500.00 |
DisclosureSEC source: 0001078782-20-000482 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,500,000 Read SEC document |
| June 12, 2020 Filed Jun 15, 2020 13:12 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 1,500,000 | $0.02 | $25,500.00 |
DisclosureSEC source: 0001078782-20-000437 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000,000 Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 15:23 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 10,000,000 | $0.00 | $46,000.00 |
DisclosureSEC source: 0001078782-20-000431 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,500,000 Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 12:13 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 25,000,000 | $0.00 | $52,500.00 |
DisclosureSEC source: 0001078782-20-000415 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,500,000 Read SEC document |
| January 06, 2020 Filed Jan 6, 2020 19:11 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 50,000,000 | $0.00 | $65,000.00 |
DisclosureSEC source: 0001078782-20-000003 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,500,000 Read SEC document |
| January 03, 2019 Filed Jan 8, 2019 16:27 UTC | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. TSOI · Entity 87112 | GrantCommon Stock | 15,000,000 | $0.01 | $75,000.00 |
DisclosureSEC source: 0001078782-19-000024 · primary_doc.xml · nonDerivative · entry 1 Ichim Thomas · CIK 0001429928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,500,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.